Bliss GVS Pharma Ltd.

₹505.95

-21.2 (-4%)

BLISSGVS Share Price

Pharmaceuticals & Biotechnology

As on July 3, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 5,351 Cr

P/E Ratio41.45

Dividend Yield0.3 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	525.22	Bearish
10-DMA	500.77	Bullish
20-DMA	471.78	Bullish
50-DMA	375.66	Bullish
100-DMA	298.87	Bullish
200-DMA	229.14	Bullish

Historical Performance

1 Year

223.7%

3 Years

531.3%

5 Years

366.1%

10 Years

444.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	9,271	8,097	7,702	7,516	7,475
Total Expenditure	7,779	6,830	6,196	6,343	6,291
Other Income	883	365	287	178	315
Operating Profit	2,376	1,632	1,794	1,351	1,498
Interest	120	81	69	104	47
Depreciation	335	294	264	187	173
Profit Before Tax	1,896	1,256	1,169	1,061	542
Consolidated Net Profit	1,291	843	755	709	150
Adjusted EPS	12	8	7	7	1

Compounded Sales Growth

10 Years:11.1

5 Years:9.9

3 Years:4.3

TTM:2.7

Compounded Profit Growth

10 Years:9.4

5 Years:13.5

3 Years:12.8

TTM:8.9

Stock Price CAGR

10 Years:18.6

5 Years:34.3

3 Years:87.2

TTM:224.1

Return on Equity

10 Years:8

5 Years:1.5

3 Years:7.2

last year:12.2

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	106	105	105	104	104
Total Reserves	11,707	10,335	9,490	8,646	7,984
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	88	373	512	428	292
Other Current Liabilities	938	734	625	582	678
Short Term Borrowings	28	229	321	460	607
Total Liabilities	14,761	13,013	12,116	11,535	11,088
Capital Work in Progress	60	207	78	28	222
Long Term Loans & Advances	295	198	147	176	244
Currents Investments	14	---	6	50	---
Short Term Loans and Advances	964	242	549	946	685
Total Current Assets	9,463	8,167	8,109	6,974	7,769
Total Assets	14,761	13,013	12,116	11,535	11,088
Adjusted Book Value	112	99	92	84	78

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 41.45, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 87.3%, indicating sustained price appreciation.
The stock carries a high beta of 1.4, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹2376 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹9271 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 3104559.1

No. of Shares: 6136 (Approx)

Performance:210.5%

P/L: ₹2104559.1

NIFTY Performance: -4.7%

1 day Top Gainers